Evidence map›Paper›PMID 41507960›Full record

ArticleRadiation oncology (London, England)2026

Comparison of radiation-induced temporal lobe injury after helical tomotherapy versus conventional intensity-modulated radiotherapy for nasopharyngeal carcinoma: a propensity score-matched cohort study.

Qin Liu, Wen-Yan Yao, Pei-Xun Xu, Yong-Wen Fang, Zhi-Yue Lin, Zong-Tai Li, Feng Chi, Wei-Xiong Xia, Sen-Kui Xu

Abstract readComparative Study
In one paragraph

Article in Radiation oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qin Liu *State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, 510060, Guangzhou, P. R. China.
Wen-Yan Yao *State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, 510060, Guangzhou, P. R. China.
Pei-Xun Xu *State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, 510060, Guangzhou, P. R. China.
Yong-Wen FangState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, 510060, Guangzhou, P. R. China.
Zhi-Yue LinState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, 510060, Guangzhou, P. R. China.
Zong-Tai LiState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, 510060, Guangzhou, P. R. China.
Feng ChiState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, 510060, Guangzhou, P. R. China. chifeng@sysucc.org.cn.
Wei-Xiong XiaState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, 510060, Guangzhou, P. R. China. xiawx@sysucc.org.cn.
Sen-Kui XuState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, 510060, Guangzhou, P. R. China. xusk@sysucc.org.cn.

Funding

the Medical Science and Technology Research Foundation of Guangdong Province No. A2020621the Natural Science Foundation of Guangdong Province of China No. 2022A1515010673the Science and Technology Planning Project of Guangdong Province, China No. 2022A0505050033
6 · The paper itself

Abstract

purposeTo compare the incidence of radiation-induced temporal lobe injury (TLI) between helical tomotherapy (HT) and conventional intensity-modulated radiotherapy (IMRT) in patients with nasopharyngeal carcinoma (NPC).

methodsWe retrospectively reviewed the medical records of NPC patients who underwent curative-intent HT or IMRT from March 2015 to December 2020 at our institution. Propensity score matching (1:1) was performed to minimize the impact of potential confounders. TLI was diagnosed based on the magnetic resonance imaging (MRI) findings. The actuarial rates of TLI were analysed by the Kaplan-Meier method and log-rank test. Univariate and multivariate analyses were used to determine prognostic factors for TLI.

results837 patients were included, of which 422 were treated with IMRT and 415 with HT. After matching, 286 patients in each group were successfully matched. The median follow-up time was 47.57 months (IQR, 37.06–58.81 months) and 46.28 months (IQR, 37.14–57.02 months) for the IMRT and HT groups, respectively. The crude incidence of TLI was 19.2% and 11.2% (P = 0.010), and the 5-year actuarial rate of TLI was 31.7% and 18.1% for the IMRT and HT groups (P = 0.011), respectively. Multivariate analysis showed that radiotherapy technique, age, sex, T stage, GTV, Dmax, D2cc, D1cc, D0.5 cc, V60 and V65 of bilateral temporal lobes (TL) were independent predictors for TLI (all P < 0.05).

conclusionReduced irradiated TL volumes and doses of HT consequently reduced incidence and severity of TLI compared to IMRT. In addition, Dmax, D2cc, D1cc, D0.5 cc, V60, and V65 of TL contributed to the TLI. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsRadiation InjuriesRadiotherapy, Intensity-ModulatedTemporal LobeAdultFemaleHumansIncidenceMaleMiddle AgedPrognosisPropensity ScoreRadiotherapy DosageRetrospective StudiesHelical tomotherapyIntensity-modulated radiation therapyNasopharyngeal carcinomaRadiation-induced temporal lobe injury

Identifiers

PMID41507960
PMCPMC12874937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.